(VIANEWS) – The Market ended the session with ONWARD MEDICAL (ONWD.BR) rising 10.95% to €2.33 on Wednesday while BEL 20 jumped 0.9% to €3,631.05.
ONWARD MEDICAL’s last close was €2.10, 66.88% below its 52-week high of €6.34.
About ONWARD MEDICAL
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Earnings Per Share
As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.93%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ONWARD MEDICAL’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 2.11M for the twelve trailing months.
Yearly Top and Bottom Value
ONWARD MEDICAL’s stock is valued at €2.33 at 21:37 EST, way below its 52-week high of €6.34 and way higher than its 52-week low of €1.85.
More news about ONWARD MEDICAL (ONWD.BR).
